Seed Biotech, Inc. Announces its Voluntary Decision to Discontinue Production, Marketing, and Sales of its Petil Product Line

Seed Biotech, Inc. continually assesses the regulatory landscape and applicable guidance documents for its products.  Based on recent assessments and discussions with the FDA, Seed Biotech, Inc. is announcing its decision to voluntarily discontinue production, marketing, and sales of its Petil product line effective August 7th, 2024.